Weighted Average Number of Shares Outstanding, Basic of Tenaya Therapeutics, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Tenaya Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q3 2021 to Q3 2025.
  • Tenaya Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 163M shares, a 89.6% increase year-over-year.
  • Tenaya Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 84.8M shares, a 15% increase from 2023.
  • Tenaya Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 73.8M shares, a 64.6% increase from 2022.
  • Tenaya Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 44.8M shares, a 153% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Tenaya Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 163M +77.2M +89.6% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 163M +77.1M +89.9% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 110M +28.9M +35.7% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 84.8M +11M +15% 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2025
Q3 2024 86.2M +12.2M +16.6% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 85.7M +12.3M +16.8% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 81M +7.88M +10.8% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 73.8M +29M +64.6% 01 Oct 2023 31 Dec 2023 10-K 10 Mar 2025
Q3 2023 73.9M +32.6M +78.7% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 73.4M +32.1M +77.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 73.1M +31.8M +77.1% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 44.8M 01 Oct 2022 31 Dec 2022 10-K 18 Mar 2024
Q3 2022 41.4M +14.5M +53.8% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 41.3M 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 41.3M 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q3 2021 26.9M 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022

Tenaya Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 84.8M +11M +15% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2025
2023 73.8M +29M +64.6% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2025
2022 44.8M +27.1M +153% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2024
2021 17.7M 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.